MEDS WEST
August 1-4, 2018
Wyndham San Diego Bayside
San Diego, California

 

MEDS EAST
October 10-13, 2018
Caribe Royale Orlando, Florida

Session Description & Objectives

Course Objectives
 

Suspecting Pituitary Disorders “What's Next?”
Ji Hyun (CJ) Chun, PA-C, BC-ADM
  1. Describe medically relevant anatomy and physiology of pituitary gland
  2. Outline appropriate evaluation of pituitary adenomas and function
  3. Describe common functional pituitary adenomas (prolactinoma, acromegaly)
  4. Acknowledge signs and symptoms of hypopituitarism
 
Adrenal Forecast: Fogginess Giving Way to Great Visibility (Part 1)
Scott Urquhart, PA-C, DFAAPA
  1. Analyze etiologies, clinical presentation, work-up, and management of primary adrenal insufficiency
  2. Investigate the clinical presentation, work-up, and treatment of hypercortisolemia as it relates to Cushing’s syndrome / disease
 
Adrenal Forecast: Fogginess Giving Way to Great Visibility (Part 2)
Scott Urquhart, PA-C, DFAAPA
  1. Examine the presentation of pheochromocytoma and implement a simple work-up for the diagnosis and proper referral
  2. Explore incidentally discovered adrenal adenomas with respect to initial discovery, imaging, work-up, treatment, and follow-up
 
New Therapies for the Treatment of Hypercholesterolemia: How to Use Them?
Joyce L. Ross, MSN, CRNP, CLS, FNLA, FPCNA
  1. Differentiate the 2013 AHA/ACC guideline recommendations from those of the NLA for the management of hypercholesterolemia
  2. Describe the mechanism of action, safety, efficacy, and differences between PCSK9 inhibitors small molecule conventional lipid-lowering therapies
  3. Apply the latest clinical trial data and guideline recommendations to devise treatment regimens for patients with hypercholesterolemia to achieve LDL-C control
 
Obesity: The Latest Skinny on the Fat Attack
Christine Kessler, MN, CNS, ANP, BC-ADM, CDTC, FAANP
  1. Review the latest epidemiologic factors likely influencing the rise of obesity in this country
  2. Describe various interconnections between fat (& selected adipokines), gut incretins & and neuropeptides in relation to satiety, calorie utilization, addictions and mood
  3. Correlate selected obesity co-morbidities to abnormal adipokine release and enteroendocrine function
  4. Relate the physiologic impact of various behavioral, pharmacologic and surgical intervention strategies in obesity prevention and treatment
  5. Review the efficacy of common over-the-counter weight loss remedies
 
Numb Toes and Other Woes: Diabetic Peripheral and Autonomic Neuropathies
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
  1. Describe the microvascular complications of retinopathy and autonomic neuropathy that affect patients suffering from diabetes mellitus
  2. Identify the clinical manifestations of these complications
  3. Apply current screening recommendations to ensure patients receive timely care
 
Vascular Risk: What's Really Important?
Joyce L. Ross, MSN, CRNP, CLS, FNLA, FPCNA
  1. Recall the relationship of elevated glucose to cardiovascular disease (CVD)
  2. State how inflammatory risk factors are contributory to CVD
  3. Discuss lipid target stratification in those with elevated glucose levels or DM
  4. Articulate the role of hypertension to increased CVD
 
Case Studies in Type 2 Diabetes: You, Me, and Your A 1 C – Achieving Goals Together
Presenters: Scott Urquhart, PA-C, DFAAPA
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
  1. Review the current ADA/EASD, and AACE guidelines for pharmacologic management of diabetes
  2. Critique the pharmacologic options with their expected A1C reduction, side effects profiles and safety concerns
  3. Apply a glucose-centric approach to incorporate oral and non-insulin injectable agents in the treatment of patients with type 2 diabetes
  4. Demonstrate how a patient-centric approach promotes empowerment and positive outcomes
 
Insulin Overview: What’s on the Menu? Tackling the Differences
Davida F. Kruger, MSN, APRN-BC, BC-ADM
  1. Participants will be able to identify a variety of insulin options available to treat people with diabetes
  2. Participants will be able to verbalize the difference in potency between u-100 insulin, and u-500 insulin
  3. Participants will be able to identify insulin available in vials and insulin pens
  4. Participants will be able to verbalize insulin on the horizon
  5. Participants will be able to effectively write a prescription for insulin
 
Case Studies Continued: Audience Interaction - Stepping Up Your Knowledge
Presenters: Donna L. Jornsay, BSN, RN, CPNP, CDE
Davida F. Kruger, MSN, APRN-BC, BC-ADM
  1. Through the use of a case presentation the attendee will be able to verbalize when and how to initiate insulin as well as tactics to support the patient to be successful
  2. Attendees will be able to verbalize the variety of insulins available as well as devices available to administer
  3. Attendees will be able to recognize potential barriers to starting insulin and the support and education the patient requires to be successful
 
Shades of Gray - MODY (Maturity-Onset Diabetes of the Young)
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
  1. Identify the monogenic types of DM
  2. Distinguish the clinical characteristics of the monogenic types of DM
  3. Evaluate the role of genetic and/or specialized testing
  4. Formulate a treatment plan that considers the underlying defect and natural progression of disease
 
Special Populations: New Onset Diabetes in the Elderly
Davida F. Kruger, MSN, APRN-BC, BC-ADM
  1. The participants will be able to verbalize treatment modalities for the elderly with diabetes
  2. The participants will be able to verbalize the heterogeneous nature of the elderly patient with diabetes and how their treatment needs differ
  3. The participants will be able to verbalize the self-care difficulties inherent in those older patients with complex medical histories
 
Sweet Expectations- Diabetes and Pregnancy
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
  1. Identify the complications related to pregestational DM that can affect mom and baby during pregnancy
  2. List the goals of preconception care for women with pregestational DM
  3. Interpret the results of the laboratory test used to screen for GDM
  4. Explain the importance of the 6 –12 week postpartum follow-up for women who developed GDM
 
New Onset Type 1 Diabetes: "Fear Not - Easing Your Concerns"
Ji Hyun (CJ) Chun, PA-C, BC-ADM
  1. Describe the pathophysiology of the autoimmune destruction involved Type 1 diabetes.M
  2. Understand how to properly diagnose T1D
  3. Describe the features suggestive of type 1 diabetes or latent autoimmune diabetes in adults (LADA)
 
Type 2 Diabetes in the Pediatric Patient
Donna L. Jornsay, BSN, RN, CPNP, CDE
  1. Participants will describe the pathophysiology of type 2 diabetes in children
  2. Participants will identify one strategy for decreasing obesity in children
  3. Participants can state the number of hours of physical activity needed to prevent pre-diabetes from becoming type 2 diabetes in children
 
Finding the Sweet Spot-The Diabetic Kidney
Kim Zuber, PAC, DFAAPA, FNKF
  1. Identify the stages of kidney disease highlighting risk factors that predict progression of CKD
  2. Highlight goals of diabetic management from multiple sources including kidney and diabetic experts
  3. Discuss urine testing with emphasis on acceptable lab deviations that may affect patient care
  4. Using CKD stages identify diabetic medications that are safe to use in each stage including FDA alerts
  5. Using a sample patient, discuss who/when/how to treat the CKD diabetic patient
 
Type 1 Diabetes: Transition of Care from Pediatric to Adult Time, Prepared?
Donna L. Jornsay, BSN, RN, CPNP, CDE
  1. Participants will be able to state one factor that negatively impacts glycemic control during this transition period
  2. Participants will identify one strategy for improving glycemic control in this age group
 
Interpreting Thyroid Labs / Case Studies in Hyperthyroidism
Christopher E. Sadler, MA, PA-C, CDE
  1. Review appropriate laboratory evaluation and interpretation for thyroid disease
  2. Describe the diagnostic work-up for hyperthyroidism
  3. Interpret laboratory, ultrasound and thyroid scan data in the diagnosis of hyperthyroidism
  4. Understand the benefits and risk of the different treatment options for hyperthyroidism
 
Case Studies in Hypothyroidism: Clearing Up Clinical Conundrums
Christine Kessler, MN, CNS, ANP, BC-ADM, CDTC, FAANP
  1. Identify those at risk of developing autoimmune hypothyroidism
  2. Discuss physical assessment and ancillary diagnostic studies to aid in diagnosis & management of hypothyroidism and subclinical hypothyroidism
  3. Describe how to safely initiate, titrate, monitor and maintain thyroid hormone replacement therapy in normal and high risk patients in selected case studies
 
Thyroiditis: "The Big Three"
Christopher E. Sadler, MA, PA-C, CDE
  1. Describe the typical presentation of thyroiditis
  2. Interpret clinical signs/symptoms, laboratory, and thyroid scan data in the diagnosis of thyroiditis
  3. List the most common forms of thyroiditis and describe how to treat each one
 
Investigating Thyroid Nodules
Christopher E. Sadler, MA, PA-C, CDE
  1. Describe appropriate work-up for thyroid nodules
  2. Identify ultrasound findings that increase the risk for thyroid malignancy
  3. Clarify when to refer a patient to an endocrinologist for FNA or further evaluation
 
Diet, Exercise, Compliance: A New Narrative for Diabetes Management
Ellen D. Mandel, DMH, MPA, MS, PA-C, RD, CDE
  1. Define narrative medicine and narrative competence: Why should we care?
  2. Describe the role of narrative competence in the care of patients with chronic disease: Diet, Exercise, Medication, and Empowerment
  3. Assess personal views through case sharing: where do we exist on the spectrum?
  4. Determine if and how to incorporate narrative concepts to improved clinical outcomes
  5. Translate methodologies to self-improvement: Reduce burn-out
 
Renal Medication Dosing: "The Good, the Bad and the Iatrogenic"
Kim Zuber, PAC, DFAAPA, FNKF
  1. By CKD stage, review common dosing errors and the pathological rationale for medication selection
  2. Using patient examples, discuss medication dosing errors that are commonly found for the CKD patient
  3. Highlight diabetic medications and those that can be safely taken by CKD patents by stage of disease
  4. A quick overview of the OTC meds dangerous for the CKD patient
  5. Highlight of AKI on CKD for the non-nephrology practitioner
 
Gut Grief: Practice Points for Fatty Liver Disease & Celiac Disease
Christine Kessler, MN, CNS, ANP, BC-ADM, CDTC, FAANP
  1. Describe symptoms and presentation of patients with celiac disease, post bariatric surgery, gastroparesis and enteropathy
  2. Review diagnostic and treatment considerations for each condition
  3. Discuss strategies for improving blood glucose control in patients affected by these GI conditions
 
Gout: What You Need to Know
Richard S. Pope, MPAS, PA-C, DFAAPA, CPAAPA
  1. Manage symptoms of gout with an appropriate long-term treatment strategy that addresses both the acute flare and the chronicity of gout
  2. Initiate appropriate steps to sustained lowering of serum urate and improving adherence to treatment around a functional patient-clinician relationship
  3. Incorporate broader aspects of gout disease management for the individual patient, such as treatment of comorbid conditions, updating medication regimens and help with establishing beneficial changes to diet and lifestyle
 

Demystifying PCOS

R. Mimi Secor, MS, MEd, FNP-C, NCMP, FAANP
  1. Describe epidemiology, pathophysiology, risks, complications, signs, symptoms
  2. Explain recommendations for diagnosing PCOS, including controversies
  3. Discuss lifestyle and pharmacologic approaches to managing PCOS
 
Depression & Chronic Disease Including Diabetes
Ellen D. Mandel, DMH, MPA, MS, PA-C, RD, CDE
  1. Incidence and screening for depression among diabetic patients
  2. Discuss causes of depression in diabetes: role of both the patient and provider
  3. Review strategies to assess and manage depression
  4. List indications for referral to a mental health provider
 
Hypercalcemia, Parathyroid Disease, Vitamin D Deficiency
Ji Hyun (CJ) Chun, PA-C, BC-ADM
  1. Review physiology of calcium homeostasis
  2. Develop and implement a work-up plan for hypercalcemia and hyperparathyroidism
  3. Be able to recall the surgical criteria for parathyroidectomy as well as applying nonsurgical treatment options
  4. Gain insight into, and the risk for, developing Vitamin D deficiency
  5. Discuss potential consequences of Vitamin D deficiency and the treatment thereof
 
Osteoporosis: Overview, Workup, Diagnosis
Richard S. Pope, MPAS, PA-C, DFAAPA, CPAAPA
  1. Review basic bone physiology and balance between breakdown and repair
  2. Review the medications which have a negative effect on bones, including steroids and others
  3. Discuss the measurements of bone density and 10 year future risk of fracture calculators
  4. Categorize medications that are FDA approved to prevent and treat osteoporosis in women and men
 
Osteoporosis: Multiple Choices. Which is Best?
Moderator: R. Mimi Secor, MS, MEd, FNP-C, NCMP, FAANP
Richard S. Pope, MPAS, PA-C, DFAAPA, CPAAPA
  1. Recognize the key points in decision making for patients with osteoporosis
  2. Relate when to treat and when not to treat based on up to date measurement parameters
  3. Appropriately recite the best medication for individuals with co-morbid conditions
  4. Assess the need for calcium and vitamin D
  5. Monitor measurement tools do we use to improve and reduced risk of fracture
 
Men's and Women’s Health Issues and Endocrine Disease
Ji Hyun (CJ) Chun, PA-C, BC-ADM
R. Mimi Secor, MS, MEd, FNP-C, NCMP, FAANP
  1. Discuss epidemiology and symptoms of menopause focusing on hot flashes, vasomotor symptoms (VMS) and atrophic vaginitis (AV), vulvovaginal atrophy (VVA)
  2. Describe diagnostic workup for hot flashes and atrophic vaginitis
  3. Explain treatment options for hot flashes and atrophic vaginitis
  4. Review current evidence in testosterone replacement therapy in elderly males
  5. Review a comprehensive diagnostic protocol to differentiate "organic" vs "nonorganic" hypogoandism
  6. Outline appropriate monitoring of patients on testosterone replacement therapy
 
Finally, Endocrine Case Studies For YOU to Solve
Christine Kessler, MN, CNS, ANP, BC-ADM, CDTC, FAANP
  1. Review case studies and identify metabolic disruptions in need intervention
  2. Identify further diagnostic/assessment data needed to determine interventions in selected Endocrinopathy case studies
  3. Develop intervention strategies required for selected endocrine case studies

 

 

Follow Us

Jointly Provided By

In Association With